A detailed history of Ameritas Investment Partners, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 150 shares of NVS stock, worth $16,584. This represents 0.0% of its overall portfolio holdings.

Number of Shares
150
Holding current value
$16,584
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$92.57 - $107.37 $13,885 - $16,105
150 New
150 $15,000
Q4 2020

Feb 12, 2021

SELL
$78.07 - $94.43 $7,494 - $9,065
-96 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$82.14 - $91.0 $7,885 - $8,736
96 New
96 $8,000
Q2 2018

Aug 13, 2018

SELL
$64.91 - $73.36 $34,726 - $39,247
-535 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$70.39 - $84.15 $30,690 - $36,689
-436 Reduced 44.9%
535 $43,000
Q3 2017

Nov 15, 2017

SELL
$74.14 - $77.27 $3,262 - $3,399
-44 Reduced 4.33%
971 $83,000
Q2 2017

Aug 15, 2017

BUY
N/A
1,015
1,015 $84,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.